NasdaqGS:VTRSPharmaceuticals
Viatris (VTRS) Is Up 7.9% After Boosting 2025 Revenue Outlook and Reaffirming Dividend
Earlier this month, Viatris Inc. announced an increase in its full-year 2025 revenue guidance to a midpoint of US$14.1 billion, up from its previous midpoint of US$13.75 billion, while also outlining continued M&A ambitions and affirming a quarterly dividend of US$0.12 per share.
This more optimistic outlook comes despite reporting a third-quarter net loss and declining revenue for the nine months ended September 30, 2025, suggesting management anticipates improvements ahead.
We'll explore...